MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Quanterix Corp

Închisă

SectorSănătate

8.06 24

Rezumat

Modificarea prețului

24h

Curent

Minim

8.04

Maxim

8.28

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+15.21% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

62M

300M

Deschiderea anterioară

-15.94

Închiderea anterioară

8.06

Sentimentul știrilor

By Acuity

77%

23%

347 / 370 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 ian. 2026, 00:16 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Drops Merger With JenaValve

11 ian. 2026, 23:46 UTC

Market Talk

Gold Rises Amid Geopolitical Risks -- Market Talk

11 ian. 2026, 23:35 UTC

Market Talk

Oil Rises Amid Middle East Tensions -- Market Talk

11 ian. 2026, 23:25 UTC

Câștiguri

Stock Futures Drift Lower With Bank Earnings, CPI on Tap -- Barrons.com

11 ian. 2026, 22:05 UTC

Market Talk

Iron Ore Outlook Weighed by Soft China Steel Markets, Rising Supply -- Market Talk

10 ian. 2026, 12:00 UTC

Achiziții, Fuziuni, Preluări

Copper Is the Prize in Mining Megadeals -- WSJ

10 ian. 2026, 09:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10 ian. 2026, 09:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

10 ian. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9 ian. 2026, 22:18 UTC

Market Talk

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 ian. 2026, 21:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9 ian. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

9 ian. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9 ian. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 ian. 2026, 21:43 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 ian. 2026, 20:39 UTC

Market Talk

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 ian. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 ian. 2026, 20:36 UTC

Achiziții, Fuziuni, Preluări

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 ian. 2026, 20:30 UTC

Market Talk

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 ian. 2026, 20:15 UTC

Market Talk

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 ian. 2026, 20:07 UTC

Market Talk

Global Equities Roundup: Market Talk

9 ian. 2026, 20:07 UTC

Market Talk

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 ian. 2026, 19:58 UTC

Achiziții, Fuziuni, Preluări

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 ian. 2026, 19:42 UTC

Market Talk

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 ian. 2026, 19:38 UTC

Achiziții, Fuziuni, Preluări

Wolters Kluwer Acquires StandardFusion >WTKWY

9 ian. 2026, 19:31 UTC

Câștiguri

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 ian. 2026, 19:28 UTC

Câștiguri

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 ian. 2026, 18:30 UTC

Market Talk

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 ian. 2026, 18:23 UTC

Market Talk

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 ian. 2026, 17:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

15.21% sus

Prognoză pe 12 luni

Medie 7.5 USD  15.21%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

347 / 370 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat